Neo - Adjuvant Chemo / Immunotherapy for the Treatment of Resectable Stage IIIA Non Small Cell Lung Cancer (NSCLC): A Phase II Multicenter Exploratory Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Nivolumab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms NADIM
- 12 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2018 Preliminary results presented at the 19th World Conference on Lung Cancer
- 05 Jun 2018 Results (n=30) assessing preliminary data on patients that completed 3 cycles and underwent surgical assessment, were presented at the 54th Annual Meeting of the American Society of Clinical Oncology.